These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 38130918)

  • 1. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma.
    Wei K; Zhang X; Yang D
    PeerJ; 2023; 11():e16643. PubMed ID: 38130918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
    Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
    Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
    Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
    Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact and immunotherapeutic implications of NETosis-related prognostic model in clear cell renal cell carcinoma.
    Mao X; Huang W; Xue Q; Zhang X
    J Cancer Res Clin Oncol; 2024 May; 150(5):278. PubMed ID: 38801430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y; He J; Jin T; Zhang Y; Ou Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 7. TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma.
    Li Q; Wei K; Zhang X; Lv Y; Li M; Zhou C; Su S; Hou D; Hou J
    Aging (Albany NY); 2023 Sep; 15(17):8908-8929. PubMed ID: 37688768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated single-cell and bulk characterization of branched chain amino acid metabolism-related key gene BCAT1 and association with prognosis and immunogenicity of clear cell renal cell carcinoma.
    Zheng J; Liu Y; Wang J; Shi J; Li L; Jiang X; Tao L
    Aging (Albany NY); 2024 Feb; 16(3):2715-2735. PubMed ID: 38309289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
    Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
    Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HDAC10 as a candidate oncogene in clear cell renal carcinoma that facilitates tumor proliferation and metastasis.
    Yang L; Wei Q; Chen X; Yang Y; Huang Q; Wang B; Ma X
    Diagn Pathol; 2024 Sep; 19(1):120. PubMed ID: 39237939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
    He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
    Front Immunol; 2021; 12():734646. PubMed ID: 34795663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma.
    Yao Q; Zhang X; Wang Y; Wang C; Chen J; Chen D
    Eur J Med Res; 2024 Jan; 29(1):73. PubMed ID: 38268058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma.
    Wu G; Li T; Chen Y; Ye S; Zhou S; Tian X; Anwaier A; Zhu S; Xu W; Hao X; Ye D; Zhang H
    Clin Exp Med; 2024 Jul; 24(1):152. PubMed ID: 38970690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma.
    Xiang J; Liu W; Liu S; Wang T; Tang H; Yang J
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16015-16030. PubMed ID: 37689589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma.
    Lv Y; Niu L; Li Q; Shao W; Yan X; Li Y; Yue Y; Chen H
    Aging (Albany NY); 2024 Jan; 16(3):2232-2248. PubMed ID: 38289619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring necrosis-associated mitochondrial gene signatures: revealing their role in prognosis and immunotherapy of renal clear cell carcinoma.
    Wang Z; Zheng F; Wei S; Li S; Xiong S; Zhang L; Wan L; Xu S; Deng J; Liu X
    Clin Exp Med; 2024 Jul; 24(1):161. PubMed ID: 39023752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
    Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.